Platform comparison and transcription profiling using high quality RNA samples purified from human breast adenocarcinoma MCF-7 cells and human skeletal muscle on the Actichip, Affymetrix U1331 2.0 and an academic 70mer oligochip to validate the Actichip

ABSTRACT: To validate Actichip, we compared this microarray with two other well-established oligonucleotide-based platforms. We used 25-mer oligonucleotide commercial chips (Affymetrix, human genome U133A 2.0) and academic arrays prepared with a 70-mer oligonucleotide set (Operon, human whole genome version 2.0). The same series of high quality RNA samples purified from human breast adenocarcinoma MCF-7 cells and from human skeletal muscle was used in our experiments.

ORGANISM(S): Homo sapiens

DISEASE(S): breast adenocarcinoma

SUBMITTER: VALLAR Laurent 

PROVIDER: E-MEXP-968 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress